Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (101-110 of 775) with videos related to

Pageof 78
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal MucosaBenno Weigmann, Markus F Neurath
Viszeralmedizin|November 12, 2015
Inflammatory Bowel Diseases: Current Medical and Surgical TherapyMarkus F Neurath, Ernst Klar
Clinical Pharmacology and Therapeutics|July 13, 2017
Precision Medicine in Inflammatory Bowel DiseasesSarah Fischer, Markus F Neurath
Lancet (London, England)|March 5, 2023
The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitisRaja Atreya, Markus F Neurath
Cytokine & Growth Factor Reviews|July 18, 2015
Interleukin-12: Functional activities and implications for diseaseSebastian Zundler, Markus F Neurath
Journal of Crohn'S & Colitis|October 21, 2024
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era?Raja Atreya, Markus F Neurath
Nature Reviews. Gastroenterology & Hepatology|April 1, 2026
Pathophysiology of colitis-associated colorectal cancerClemens Neufert, Markus F Neurath
Current Protocols in Pharmacology|February 2, 2012
Chemically induced mouse models of colitisMaximilian J Waldner, Markus F Neurath
Immunotherapy|April 20, 2012
Potential avenues for immunotherapy of colitis-associated neoplasiaMaximilian J Waldner, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|March 2, 2017
Mechanisms of Immune Signaling in Colitis-Associated CancerMaximilian J Waldner, Markus F Neurath
Pageof 78

Showing results (101-110 of 775) with videos related to

Sort By:
Pageof 78
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal MucosaBenno Weigmann, Markus F Neurath
Viszeralmedizin|November 12, 2015
Inflammatory Bowel Diseases: Current Medical and Surgical TherapyMarkus F Neurath, Ernst Klar
Clinical Pharmacology and Therapeutics|July 13, 2017
Precision Medicine in Inflammatory Bowel DiseasesSarah Fischer, Markus F Neurath
Lancet (London, England)|March 5, 2023
The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitisRaja Atreya, Markus F Neurath
Cytokine & Growth Factor Reviews|July 18, 2015
Interleukin-12: Functional activities and implications for diseaseSebastian Zundler, Markus F Neurath
Journal of Crohn'S & Colitis|October 21, 2024
IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era?Raja Atreya, Markus F Neurath
Nature Reviews. Gastroenterology & Hepatology|April 1, 2026
Pathophysiology of colitis-associated colorectal cancerClemens Neufert, Markus F Neurath
Current Protocols in Pharmacology|February 2, 2012
Chemically induced mouse models of colitisMaximilian J Waldner, Markus F Neurath
Immunotherapy|April 20, 2012
Potential avenues for immunotherapy of colitis-associated neoplasiaMaximilian J Waldner, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|March 2, 2017
Mechanisms of Immune Signaling in Colitis-Associated CancerMaximilian J Waldner, Markus F Neurath
Pageof 78